The integration enables Eze OMS users to send option orders directly into DerivatEx and receive execution reports back through the Eze OMS blotter. In addition, Eze OMS users will now be able to access the recently released ConvergEx suite of options algorithms, designed to help clients limit their market impact and find liquidity across all options exchanges.
The DerivatEx system gives Eze OMS users full electronic direct market access (DMA) to all U.S. listed options exchanges and provides the ability to sweep those exchanges in order to seek enhanced liquidity and potential price improvement.
Tom Gavin, CEO of Eze Castle Software notes, âWe continue to leverage the capabilities within ConvergEx to expand our Eze OMS offering and provide our clients a variety of choices for execution. This integration gives our clients the flexibility to easily execute options orders through the innovative DerivatEx platform.â
âWe are constantly seeking ways to keep ConvergEx customers ahead of the curve. With this integration, Eze OMS customers now have seamless access to both the DerivatEx low latency options execution platform and our advanced execution algorithms,â stated Anthony J. Saliba, CEO of LiquidPoint. âThe ânatural fitâ of the Eze and LiquidPoint offerings brings the client the best integrated solution.â
Eze OMS is a multi-asset class system that offers buy-side firms execution integration for various asset classes to optimize the investment workflow. It is a product of Eze Castle Software LLC, a member company of BNY ConvergEx Group. It is used by over 310 buy-side firms to manage their investment process. Eze Castle Software has also partnered with Credit Suisse and UBS to integrate their options algorithms into the Eze OMS.